Differences
This shows you the differences between two versions of the page.
Next revision | Previous revision | ||
triglyceride [2025/01/27 17:31] – created admin | triglyceride [2025/01/28 04:31] (current) – admin | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | |[[clinical_biochemistry_section|Home]]|[[clinical_biochemistry|]]|[[examination_procedures|]]| | ||
- | ' | + | Triglyceride Examination Procedure |
- | Purpose of examination: | + | **1.Purpose of examination: |
- | ●Triglyceride estimation from serum or plasma by Glycerol Phosphate Oxidase | + | Triglyceride estimation from serum or plasma by Glycerol Phosphate Oxidase. |
- | Responsibility and Authority: | + | **2.Responsibility and Authority:** |
- | ● Calibration: | + | |
- | ● Quality Control: Technician | + | |
- | ● Routine operation: Technician | + | |
- | ● Overall Monitoring: Quality Manager | + | |
- | Sample Details: | + | **3.Sample Details:** |
- | ● Type of Sample: Serum, | + | |
- | ● Type of container and additives: Plain without any additives | + | |
- | ● Patient Preparation: | + | |
- | ● Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours | + | |
- | ● Handling and transport: As per Primary Sample collection manual | + | |
- | ● Storage: 24 hours at 2-8° C | + | |
- | Required Equipment: | + | **4.Required Equipment:** |
- | ●Centrifuge, Auto-Pipette, | + | Centrifuge, Auto-Pipette, |
- | Required reagents: | + | **5.Required reagents:** |
- | R1 ATP (2.5 mmol/ | + | |
- | | + | |
- | 4-aminoantipyrine (0.4 mmol/ | + | |
- | | + | |
- | Peroxidase (horseradish) (> 2000 U/L), | + | |
- | | + | |
- | GPO (microbial) (> 6000 U/L), | + | |
- | | + | |
- | Reagent Handling | + | **6.Reagent Handling** |
- | ● Remove any air bubbles present in the reagents with a new applicator stick, or allow the reagents to settle at the appropriate storage temperature to allow the bubbles to dissipate. To minimize volume depletion, do not use a transfer pipette to remove bubbles | + | |
- | Reagent Storage and stability | + | |
- | Unopened reagent stable at 2-8°C until expiration date. | + | |
+ | * On board System temperature reagent is stable for 30 days | ||
+ | * Instability or deterioration should be suspected if there are precipitates, | ||
+ | * contamination, | ||
- | On board System temperature reagent is stable for 42 days | ||
- | Instability or deterioration should be suspected if there are precipitates, | ||
- | contamination, | ||
- | Calibration Procedure: | ||
- | ● Consolidated Chemistry Calibrator | ||
- | ● Frequency: | + | **7.Calibration Procedure: |
- | Reagent lot change | + | * Consolidated Chemistry Calibrator |
- | QC out of range | + | * Frequency: |
- | After service or maintenance | + | |
- | Replacement in any parts of Instrument | + | |
- | Procedure: | + | |
- | Start the equipment.WDI abbotte fully.docx | + | |
- | Calibrators are ready to use. | + | |
- | Put calibrator 15-20 minutes at room temperature | + | |
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation. | + | |
- | Take a 150 µl calibrator solution in separate aliquots. | + | |
- | Go to the calibration and give the calibration order. | + | |
- | Verify calibration with at least two levels of controls. | + | |
- | If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. | + | |
- | Quality control | + | **8.Procedure:** |
- | Name: Bio Rad Level 1 & 2 | + | - Start the equipment.WDI abbotte fully.docx |
- | Frequency: As per Quality Control Procedure | + | - Calibrators |
- | ●Procedure for Reconstitution of IQC | + | - Put calibrator 15-20 minutes at room temperature |
- | Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. | + | - Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent |
- | Leave to stand for 30 min in the dark place. | + | |
- | Swirl gently several times during the reconstitution period to ensure that the contents | + | - Go to the calibration and give the calibration order. |
- | Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. | + | |
- | Prepare aliquots of 150 µl from the reconstituted QC material. | + | - If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary. |
- | Store these aliquots at -15° C to -20° C. | + | |
- | Prior to use, make sure that aliquots should | + | |
+ | **9.Quality control Procedure: | ||
+ | * ** Name:** Bio Rad Level 1 & 2 | ||
+ | * **Frequency: | ||
- | ●Procedure | + | **Procedure |
- | Press Control order | + | - Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette. |
- | Select Assay / | + | - Leave to stand for 30 min in the dark place. |
- | Select | + | - Swirl gently several times during |
- | Give Carrier Number and Position number | + | - Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted. |
- | Press F3 / Add order | + | - Prepare aliquots of 150 µl from the reconstituted QC material. |
- | Put respected carrier in RSH rack | + | - Store these aliquots at -15° C to -20° C. |
- | Check IQC results, in case outliers call residents. | + | - Prior to use, make sure that aliquots should be at room temperature for at least 15 min. |
- | Principle of the procedure used for examinations: | + | **Procedure |
- | The glycerol is phosphorylated by adenosinetriphosphate (ATP) with glycerol kinase (GK) to produce glycerol-3-phosphate and adenosine diphosphate (ADP). Glycerol-3-phosphateis oxidized | + | |
+ | | ||
+ | | ||
+ | | ||
+ | | ||
+ | | ||
+ | - Check IQC results, in case outliers call residents. | ||
- | | + | **10.Principle |
- | ● Required SampleVolume: | + | Triglycerides are enzymatically hydrolyzed by lipase to free fatty acids and glycerol. The glycerol is phosphorylated by adenosine triphosphate (ATP) with glycerol kinase (GK) to produce glycerol-3-phosphate and adenosine diphosphate (ADP). Glycerol-3-phosphate is oxidized |
- | ● Temperature: 37° | + | |
- | Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample | + | |
- | ●Procedure to run Patient sample | + | |
- | Press Patient order | + | |
- | Select Assay /Panel, to be run. | + | |
- | Give Carrier Number | + | |
- | Press F3 / Add order | + | |
- | Put respected carrier | + | |
- | Performance Characteristics: | + | **11.Sample Preparation:** |
- | ● Linearity: up to 1420 mg/dL | + | * Required SampleVolume: 150 µl of the sample |
- | ● The limit of detection (LOD): 5.0 mg/dL | + | * Temperature: 37° |
- | ● The limit of quantification(LOQ): 6.2 mg/dL | + | |
- | ● Unit: mg/dL | + | |
+ | **Procedure to run Patient sample** | ||
+ | - Press Patient order | ||
+ | - Select Assay /Panel, to be run. | ||
+ | - Give Carrier Number and Position number | ||
+ | - Press F3 / Add order | ||
+ | - Put respected carrier in RSH rack | ||
+ | **12.Performance Characteristics**: | ||
+ | - Linearity: up to 1420 mg/dL | ||
+ | - The limit of detection (LOD): 0.62 mg/dL | ||
+ | - The limit of quantification(LOQ): | ||
+ | - Unit: mg/dL | ||
- | Normal and critical ranges: | + | **Normal and critical ranges:** |
- | Parameter | + | **Triglyceride** |
- | Desirable | + | ^Desirable^ Borderline High^High^ |
- | Near/ Above optimal | + | |< |
- | Borderline | + | |
- | High | + | |
- | Very High | + | |
- | Triglyceride | + | **13.Laboratory Clinical interpretation: |
- | < 150 mg/dL | + | The common causes of hyperlipidemia is nephrosis, |
+ | **14.Interference and cross reaction:** | ||
- | 150-199 | + | InterferingSubstance |
- | 200-499 | + | * No interference from Bilirubin up to7.5 mg/dL |
- | >/= 400 mg/dL | + | * No interference from Hemoglobin up to750 mg/dL |
+ | * No interference from Ascorbate up to 1.5 mg/dl | ||
+ | * No interference from Acetamenophen up to200mg/dl. | ||
+ | * No interference from Dipyrone up to100mg/dl. | ||
+ | * No interference from N acetyl L cystenine up to800 mg/dl | ||
+ | **15.Potential source of variation: | ||
+ | * Turn around time (TAT): | ||
+ | * Routine: 6.0 hours | ||
+ | * Urgent: 2.0 hours | ||
+ | **16.Recording of observation: | ||
+ | * Software backup | ||
+ | * Machine raw data | ||
+ | **17.torage & Disposal of waste:** Follow storage & discard procedure | ||
- | | + | **18.Environmental & Safety control:** |
- | Measurement of triglyceride is important in the diagnosis and management of hyperlipidemia. These diseases can be genetic or secondary to other disorders including nephrosis, diabetes mellitus, and endocrine disturbances. | + | |
- | | + | **Reagent R1** contains sodium azide.contact with acids liberates very toxic gas |
- | No interference from Bilirubin up to7.5 mg/dL | + | **19.Precautions: |
- | No interference from Hemoglobin up to750 mg/dL | + | |
- | No interference from Ascorbate up to 1.5 mg/dl | + | |
- | No interference from Acetamenophen up to200mg/dl. | + | |
- | No interference from Dipyrone up to100mg/dl. | + | |
- | No interference from N acetyl L cystenine up to800 mg/dl | + | |
- | + | ||
- | Potential source of variation: | + | |
- | Turn around time (TAT): | + | |
- | Routine: 6.0 hours | + | |
- | Urgent: 2.0 hours | + | |
- | + | ||
- | | + | |
- | Software backup | + | |
- | Machine raw data | + | |
- | Storage & Disposal of waste: Follow storage & discard procedure | + | |
- | Environmental & Safety control: | + | |
- | Reagent R1 contains sodium azide.contact with acids liberates very toxic gas | + | |
- | Precautions: | + | |
- | Wear protective gloves / protective clothing / eye protection | + | |
- | Do not breathe mist / vapors / spray | + | |
- | Wash hands thoroughly after handling | + | |
- | Keep only in original container | + | |
. | . | ||
- | References: | + | **20.References:** |
- | + | | |
- | US department of labor, | + | |
- | US department of health and human services. Biosafety in MIcrobiological and biomedical laboratories. | + | |
- | World health organization. Biosafety manual,3rd edition. | + | |
- | World health organization. Biosafety manual,3rd edition. | + | |
- | Clinical and laboratory std institute . Protection of Laboratory workers from oocupationally acquired infection; Approved guideline -4th edition. | + | |
- | Burtis CA,Ashwood ER, | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | |**Printed copy of this document is considered uncontrolled.** It should be compared with controlled electronic copy before use| | ||
+ | ^ Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH), | ||
+ | ^Document No.1^**Document Name**: Triglyceride Examination Procedure^**Unique ID**:LSSTH /BIOCHEM/ SOP-5^^ | ||
+ | ^Issue No. : 01^Issue Date : | ||
+ | ^Amend No.^ Amend Date ^Prepared by: Section Incharge^Approved & Issued by: HOD, |